Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Learn more about HealthTree
Demystifying the Diagnosis: MDS Basics and Understanding Your Lab Reports image

Demystifying the Diagnosis: MDS Basics and Understanding Your Lab Reports

Can't make it to the event?
We send a recording to all registered participants of the event!
Oct 29, 2026
01:00PM - 02:00PM EDT
Online Event
Overview

Join the HealthTree Foundation for an empowering virtual session designed to help newly diagnosed MDS patients take control of their health journey with confidence. Led by world-renowned MDS expert Dr. David Sallman, this webinar breaks down the fundamentals of myelodysplastic syndromes into clear, accessible concepts. You will learn how to make sense of your pathology reports, navigate complex diagnostic terms, and interpret routine blood counts without unnecessary anxiety. Gain the clarity you need to feel informed, proactive, and ready to partner with your care team.

Agenda
1:00 PM
Introduction
Dalton Bean

Dalton introduces the agenda for the event and the speaker Dr. David Sallman

1:05 PM
Presentation
Dr. David Sallman

Dr. Sallman breaks down basic MDS concepts

1:35 PM
Questions & Answers
Audience

Come prepared to learn and ready to ask questions!

Speakers & Moderators
Healthtree contact Dalton Bean

Dalton Bean

Dalton joined HealthTree in 2024 as the MPNs and MDS Program Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.
Healthtree contact Dr. David Sallman

Dr. David Sallman

Dr. David Sallman is an Associate Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr. Sallman’s clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr. Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center. His research interests focus on the development of novel, targeted therapeutic strategies (Phase I and II clinical trials) for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML), based on the underlying mutational drivers of each disease.